Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Spironolactone and Insulin Resistance in Chronic Heart Failure (CHF)
This study has been completed.
Study NCT00664222 Information provided by Tottori University Hospital
First Received: April 18, 2008 Last Updated: April 21, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Chronic Stable Heart Failure
Additional conditions recognized in this trial
Heart Failure
Insulin Resistance
More general conditions related to this trial
Cardiovascular Diseases
Glucose Metabolism Disorders
Heart Diseases
Hyperinsulinism
Metabolic Diseases
Interventions listed in this trial
spironolactone + furosemide
Additional drug interventions recognized in this trial
Furosemide
Insulin
Spironolactone
More general drug interventions related to this trial
Aldosterone Antagonists
Cardiovascular Agents
Diuretics
Hormone Antagonists
Hormones, Hormone Substitutes, and Hormone Antagonists
Hypoglycemic Agents
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Natriuretic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sodium Potassium Chloride Symporter Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Tottori University Hospital
Back to top of Main Content
